Correlation Between Xcel Brands and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Xcel Brands and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xcel Brands and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xcel Brands and Monopar Therapeutics, you can compare the effects of market volatilities on Xcel Brands and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xcel Brands with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xcel Brands and Monopar Therapeutics.
Diversification Opportunities for Xcel Brands and Monopar Therapeutics
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Xcel and Monopar is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Xcel Brands and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Xcel Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xcel Brands are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Xcel Brands i.e., Xcel Brands and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Xcel Brands and Monopar Therapeutics
Given the investment horizon of 90 days Xcel Brands is expected to under-perform the Monopar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Xcel Brands is 1.98 times less risky than Monopar Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Monopar Therapeutics is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest 1,467 in Monopar Therapeutics on August 31, 2024 and sell it today you would earn a total of 786.00 from holding Monopar Therapeutics or generate 53.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xcel Brands vs. Monopar Therapeutics
Performance |
| Timeline |
| Xcel Brands |
| Monopar Therapeutics |
Xcel Brands and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xcel Brands and Monopar Therapeutics
The main advantage of trading using opposite Xcel Brands and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xcel Brands position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Xcel Brands vs. H M Hennes | Xcel Brands vs. Under Armour C | Xcel Brands vs. H M Hennes | Xcel Brands vs. Oxford Industries |
| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |